Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Pancreatic Neoplasms 2Mesothelioma 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Turcot syndrome 1Stomach Neoplasms 1Solid Tumors 1Sarcoma 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Microsatellite Instability 1Mesothelioma, Malignant 1Mesothelin-positive Advanced Refractory Solid Tumors 1Lung Neoplasms 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1Advanced Solid Tumor 1

Interventions

Paclitaxel 15atezolizumab 11Gemcitabine 11Carboplatin 9pembrolizumab 8Docetaxel 8Bevacizumab 8Irinotecan 7Injections 6Cetuximab 6Capecitabine 6Sunitinib 5Leucovorin 5Fluorouracil 5Cyclophosphamide 5tocilizumab 4pazopanib 4olaparib 4navitoclax 4liposomal doxorubicin 4Topotecan 4Oxaliplatin 4Nivolumab 4Erlotinib Hydrochloride 4temsirolimus 3spartalizumab 3lenvatinib 3fludarabine 3cobimetinib 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumors × fludarabine phosphate × Other solid neoplasm × Clear all
NCT06066424 2026-05-15

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

M.D. Anderson Cancer Center

Phase 1 Recruiting
54 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡